Drawing for HDX

USPTO serial 86370488

HDX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
NOVAKOVIC, MIROSLAV
Law office
TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with HDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark Harrison

MARK HARRISON VENABLE LLPPO BOX 34385WASHINGTON, DC 20045-9998UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Custom cell-line engineering services; scientific research in the field of genetics and genetic engineering, namely, gene-editing services, DNA modelling services, gene engineering services, establishing patient genotypes; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; pharmaceutical research services; drug discovery services; research and development services for lead identification and validation; research and development services for target identification and validation; pharmaceutical research, namely, identification of patient-relevant drug targets, optimisation of drug candidates for clinical development; diagnostic services; medicinal research services, namely, hit discovery and hit to lead services; research and development services in the nature of creating libraries and collections of cells and cell lines, chemicals and compounds; research and development services in the nature of creating libraries and collections of normal and mutated genes; research and development services relating to targeting therapies to individuals; research and development services relating to combining therapies for individuals; research and development relating to reagents; scientific research in the field of disease modelling; medical and scientific research, namely, designing and conducting clinical trials for others; research and development in re-positioning existing drugs from other therapeutic indicationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 9, 2015MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 9, 2015ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 11, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 4, 2014DOCKASSIGNED TO EXAMINER—
Dec 3, 2014ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 3, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 25, 2014ALIEASSIGNED TO LIE—
Nov 21, 2014MAILPAPER RECEIVED—
Sep 2, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 22, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance